Derivation of male germ cells from induced pluripotent stem (iPS) cells: a novel and crucial source for generating male gametes.

ne of the most significant findings in recent stem cell research is the establishment of the induced pluripotent stem (iPS) cells, because they could have critical implications in both regenerative and reproductive medicine. Male gametes play a crucial role in transmitting genetic information to subsequent generations, and notably there are more and more patients with azoospermia, due to genetic and environmental factors. Recent advancements on generation of male gametes from human iPS cells would bring great promise to produce patient own male gametes for treating male infertility and provide an excellent platform for unveiling molecular mechanisms of male germ cell development. Exciting progress has recently been made in the derivation of primordial germ cells (PGCs), various kinds of male germ cells, and eventually male gametes from mouse and human induced pluripotent stem (iPS) cells. These studies would provide an ideal platform for unveiling molecular mechanisms of male germ cell development and open new opportunities for treating male infertility in the future. Male gametes play a critical role in transmitting genetic information to subsequent generations. Spermatogenesis is a complex process by which male germ-line stem cells (also known as spermatogonial stem cells) self-renew and differentiate into haploid spermatozoa, which involves three major stages: mitosis, meiosis and spermiogenesis. Any error at these stages could result in male infertility, which affects millions of people worldwide. It has been estimated that 10%– 15% of couples are infertility, and male factor accounts for half of these cases. Currently sperm donation by genetically unrelated donors is the only available option for many patients with azoospermia. Embryonic stem (ES) cells possess the capability to differentiate into male gametes in vivo or in vitro. However, human ES cells involve egg donation and embryo damage and human ES cell-derived male gametes are genetically unrelated to the patient in need of fertility treatment, which would discourage this route of treatment. Male gametes derived from patient-specific iPS cells would overcome these issues, and thus there is a great potential to obtain male gametes with genetic information from iPS cells of patients. Hayashi et al. combined the approach using the in vitro induction and transplantation assay to obtain male germ cells from mouse iPS cells. They first induced iPS cells to differentiate into epiblast-like cells that were committed to become the PGC-like cells with the stimulation of bone morphogenetic protein 4. Mouse PGC-like cells derived from iPS cells were transplanted into the seminiferous tubules of mice and they exhibited proper spermatogenesis. Significantly, functional assay further revealed that spermatozoa generated from iPS cell-derived PGC-like cells were able to fertilize the oocytes by intracytoplasm sperm injection and eventually gave rise to fertile offspring after embryo transfer. It has been verified that PGC-like cells derived from mouse iPS cells can form functional sperm. Mouse iPS cells derived from adult hepatocytes and fibroblasts were capable of differentiating into PGC-like cells, which reflects the independence of the origin of somatic cells. More recently, mouse iPS cell-derived PGC-like cells were shown to reconstitute seminiferous tubules by ectopic grafting into the dorsal skin of mice or transplantation to seminiferous tubules of mouse testes. Mouse PGC-like cells could differentiate into late stages of male germ cells, including various spermatocytes and haploid spermatids. These studies illustrate that derivation of PGC-like cells in culture is an essential step for male germ cell specification pathway from iPS cells. Nevertheless, there is no report showing that functional male gametes can be obtained from mouse or human iPS cells in vitro. Human PGCs could also be generated from human iPS cells when cocultured with human fetal gonadal cells, although they did not initiate efficiently the process of imprint erasure. Strikingly, human iPS cells were induced to differentiate into post-meiotic male germ cells including haploid cells. Even though functional sperm was not determined, this study may bring great promise to produce human personalized male gametes from iPS cells of patients with male infertility. Several issues remain to be solved before iPS cell-derived male gametes could be used for clinical application. First of all, safety risk is a major concern of iPS cell-derived male gametes, because pluripotent transcription factors were used to reprogram somatic cells to become iPS cells and some of these transcription factors (e.g., Myc) belong to oncogenes. Interestingly, recent study has shown that other combinations of factors excluding Myc could produce mouse and human iPS cells. Notably, recombinant proteins or chemical compounds have been used to generate iPS cells. These reprogramming approaches using recombinant proteins or chemical compounds could reduce significantly the risk of Clinical Stem Cell Research Center, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China and State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China Correspondence: Professor Z He ([email protected]) O Asian Journal of Andrology (2012) 14, 516–517 2012 AJA, SIMM & SJTU. All rights reserved 1008-682X/12 $32.00